Project Details
| Status | Active |
|---|---|
| Effective start/end date | 28/11/25 → 31/12/27 |
Clinical Trial Phase
- Phase III (a & b)
- External Sponsor
A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)
- Brown, Adam (Primary Chief Investigator (PCI))
Project: Research